Literature DB >> 16443768

A severe diabetic nephropathy model with early development of nodule-like lesions induced by megsin overexpression in RAGE/iNOS transgenic mice.

Reiko Inagi1, Yasuhiko Yamamoto, Masaomi Nangaku, Nobuteru Usuda, Hiroshi Okamato, Kiyoshi Kurokawa, Charles van Ypersele de Strihou, Hiroshi Yamamoto, Toshio Miyata.   

Abstract

Many factors are involved in the pathogenesis of diabetic nephropathy. A single gene abnormality may be prerequisite but insufficient to the disease to manifest. It is therefore only when a second or sometimes a third damage is associated that the consequences of pathogenic phenotypes become evident. We generated the triple transgenic mice overexpressing megsin (a novel glomerular-specific serpin), a receptor for advanced glycation end products (RAGE), and inducible nitric oxide synthase (iNOS). Compared with the single- or two-gene transgenic mice, the triple transgenic mice developed, at an early age (16 weeks), severe albuminuria and renal damage with all of the characteristics of human diabetic nephropathy (i.e., glomerular hypertrophy, diffuse mesangial expansion, inflammatory cell infiltration, and interstitial fibrosis). Interestingly, 30-40% of glomeruli exhibit nodule-like lesions. Oxidative and carbonyl stress makers (pentosidine, N(epsilon)-carboxymethyllysine, and 8-hydroxy-deoxyguanosine) were significantly higher in the triple transgenic mice. The iNOS transgenic mice have a diabetes phenotype, the renal consequences of which are moot, and the superimposition of RAGE leads to more conspicuous manifestations. By additional overexpression of megsin, a gene known to be involved in mesangial proliferation and expansion, these local consequences become dramatically manifest and approximate those observed in human pathology. This multiple hit approach is of interest in consideration of the sequential events during development of diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16443768     DOI: 10.2337/diabetes.55.02.06.db05-0702

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  25 in total

1.  Deletion of bone-marrow-derived receptor for AGEs (RAGE) improves renal function in an experimental mouse model of diabetes.

Authors:  Greg Tesch; Karly C Sourris; Shaun A Summers; Domenica McCarthy; Micheal S Ward; Danielle J Borg; Linda A Gallo; Amelia K Fotheringham; Allison R Pettit; Felicia Y T Yap; Brooke E Harcourt; Adeline L Y Tan; Joshua Y Kausman; David Nikolic-Paterson; Arthur R Kitching; Josephine M Forbes
Journal:  Diabetologia       Date:  2014-06-24       Impact factor: 10.122

Review 2.  RAGE and the pathogenesis of chronic kidney disease.

Authors:  Vivette D'Agati; Ann Marie Schmidt
Journal:  Nat Rev Nephrol       Date:  2010-04-27       Impact factor: 28.314

3.  Discovery of genes related to diabetic nephropathy in various animal models by current techniques.

Authors:  Jun Wada; Lin Sun; Yashpal S Kanwar
Journal:  Contrib Nephrol       Date:  2011-01-20       Impact factor: 1.580

4.  Peroxynitrite-induced nitration of cyclooxygenase-2 and inducible nitric oxide synthase promotes their binding in diabetic angiopathy.

Authors:  Yanning Li; Jinsheng Qi; Kun Liu; Bin Li; Hui Wang; Jinhai Jia
Journal:  Mol Med       Date:  2010-06-30       Impact factor: 6.354

5.  Endogenous Secretory RAGE as a Novel Biomarker for Metabolic Syndrome and Cardiovascular Diseases.

Authors:  Hidenori Koyama; Hiroshi Yamamoto; Yoshiki Nishizawa
Journal:  Biomark Insights       Date:  2007-09-17

6.  Genetic analysis of diabetic nephropathy on chromosome 18 in African Americans: linkage analysis and dense SNP mapping.

Authors:  Caitrin W McDonough; Meredith A Bostrom; Lingyi Lu; Pamela J Hicks; Carl D Langefeld; Jasmin Divers; Josyf C Mychaleckyj; Barry I Freedman; Donald W Bowden
Journal:  Hum Genet       Date:  2009-12       Impact factor: 4.132

7.  Diabetic albuminuria is due to a small fraction of nephrons distinguished by albumin-stained tubules and glomerular adhesions.

Authors:  Patricia M Kralik; Yunshi Long; Ye Song; Lu Yang; Haiyang Wei; Susan Coventry; Shirong Zheng; Paul N Epstein
Journal:  Am J Pathol       Date:  2009-07-02       Impact factor: 4.307

Review 8.  Nodular lesions and mesangiolysis in diabetic nephropathy.

Authors:  Takashi Wada; Miho Shimizu; Hitoshi Yokoyama; Yasunori Iwata; Yoshio Sakai; Shuichi Kaneko; Kengo Furuichi
Journal:  Clin Exp Nephrol       Date:  2012-10-26       Impact factor: 2.801

9.  Inhibitors of Advanced Glycation End Product (AGE) Formation and Accumulation.

Authors:  Karly C Sourris; Anna Watson; Karin Jandeleit-Dahm
Journal:  Handb Exp Pharmacol       Date:  2021

Review 10.  Historical chronology of basic and clinical research in diabetic nephropathy and contributions of Japanese scientists.

Authors:  Jun Wada; Hirofumi Makino
Journal:  Clin Exp Nephrol       Date:  2009-04-11       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.